On Friday, the Food and Drug Administration greenlit Pfizer’s treatment for adults with moderate to severe hemophilia B. Hemophilia B is a blood condition caused by insufficient amounts of a certain protein needed to form blood clots. Without sufficient levels of the protein called factor IX, those…
Read More...
